发明名称 |
CAI-BASED SYSTEMS AND METHODS FOR THE LOCALIZED TREATMENT OF UVEITIS |
摘要 |
This invention relates to the treatment of uveitis, in particular posterior infectious uveitis. In specific embodiments, the invention provides for methods of treating uveitis and/or infectious uveitis comprising administration of a sustained-release system containing 5-amino-[4-(4-chlorobenzoyl)-3,5-dichlorobenzyl]-1,2,3-triazole-4-carboxamide) and optionally a glucocorticoid. In one embodiment, the glucocorticoid is dexamethasone. In another embodiment, the sustained-release system comprises a polymer such as e.g. polylactic-coglycolic acid. |
申请公布号 |
US2016106717(A1) |
申请公布日期 |
2016.04.21 |
申请号 |
US201514884514 |
申请日期 |
2015.10.15 |
申请人 |
Gen Pharma Holdings LLC |
发明人 |
Gupta Sunil |
分类号 |
A61K31/4192;A61K45/06;A61K31/573;A61K47/48;A61K47/34;A61K9/00 |
主分类号 |
A61K31/4192 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating uveitis in a patient comprising administering to the patient a sustained-release system comprising a pharmaceutically effective amount of 5-amino-[4-(4-chlorobenzoyl)-3,5-dichlorobenzyl]-1,2,3-triazole-4-carboxamide) (CAI). |
地址 |
Pensacola FL US |